Tomoko Inoue
Red Capital Co., Ltd. Managing Partner
MBA, Ph.D.
Policy
Forging the Future of Humanity Through Science
— Investing in Technologies and Talent That Will Reshape the World
Scroll
Vision
We believe in the boundless potential of humanity. Throughout history, we have turned the impossible into reality, often in ways beyond imagination, creating a richer world. To ensure that humanity continues to evolve in a way that honors our true essence, we join forces with entrepreneurs across the globe to build a brighter future.
About
| Company Name | Red Capital Co., Ltd. |
|---|---|
| Founded | 2024 |
| Location | 18F Ebisu Garden Place Tower, 4-20-3 Ebisu, Shibuya-ku, Tokyo, Japan |
| Managing Partners | Maiko Katadae, Tomoko Inoue |
| Outside Director | Gen Tsuchikawa |
| Business Description | Red Capital is a healthcare-focused venture capital firm dedicated to advancing innovation across the life sciences ecosystem. We leverage a dual investment strategy: a "Seed-Driven" approach, supporting companies from inception through exit, and "Ecosystem Complementary" approach, enabling sustained growth through secondary investments. Beyond capital provision, we deliver tailored, stage-specific support to portfolio companies, partnering with them over the long term to maximize value creation. We collaborate with visionary founders and researchers to turn scientific breakthroughs into real-world impact in healthcare and life sciences. |
| Core Focus Areas | Biotech, Medtech and Digital Health. |
| Investment Approach | A hybrid approach combining primary and secondary investments |
| Fund Under Management | Red 1 Healthcare Limited Partnership |
